{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:36:25Z","timestamp":1778592985189,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/maj.0b013e318236e02d","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T09:26:47Z","timestamp":1321694807000},"page":"483-489","source":"Crossref","is-referenced-by-count":43,"title":["Acute or Chronic Life-Threatening Diseases Associated With Epstein-Barr Virus Infection"],"prefix":"10.1016","volume":"343","author":[{"given":"Motohiko","family":"Okano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e318236e02d_bb0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14787210.5.3.403","article-title":"Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients","volume":"5","author":"Okano","year":"2007","journal-title":"Exp Rev Anti Infect Ther"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"i","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0015","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.56.6.1699","article-title":"Precipitating antibody in human serum to an antigen present in Burkitt\u2019s lymphoma cells","volume":"56","author":"Old","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"226","author":"zur Hauzen","year":"1970","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt\u2019s tumor-associated herpestype virus to infectious mononucleosis","volume":"59","author":"Henle","year":"1968","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/beha.1999.0068","article-title":"Haematological associations of Epstein-Barr virus infection","volume":"13","author":"Okano","year":"2000","journal-title":"Bailliere\u2019s Clin Haematol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0040","series-title":"The human herpesviruses","first-page":"107","article-title":"Epstein-Barr virus","author":"Leibowitz","year":"1993"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0045","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0002-9440(10)65193-0","article-title":"Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations","volume":"155","author":"Chu","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.73.2.965-975.1999","article-title":"Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt\u2019s lymphoma reflect virus strains prevalent in different geographic areas","volume":"73","author":"Habeshaw","year":"1999","journal-title":"J Virol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0055","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-8652(199610)53:2<111::AID-AJH8>3.0.CO;2-2","article-title":"Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis","volume":"53","author":"Okano","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pbc.22310","article-title":"Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan","volume":"54","author":"Ohga","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0075","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM198109243051305","article-title":"Burkitt\u2019s lymphoma","volume":"305","author":"Ziegler","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0090","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/JB.91.3.1248-1256.1966","article-title":"Immunofluorescence in cells derived from Burkitt\u2019s lymphoma","volume":"91","author":"Henle","year":"1966","journal-title":"J Bacteriol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","article-title":"Epidemiological evidence for the causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma: results of the Ugandan prospective study","volume":"274","author":"de-The","year":"1978","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0145-2126(97)00126-4","article-title":"High susceptibility of an Epstein-Barr virus-converted Burkitt\u2019s lymphoma cell line to cytotoxic drugs","volume":"21","author":"Okano","year":"1997","journal-title":"Leuk Res"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0105","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata","volume":"73","author":"Kumano","year":"1999","journal-title":"J Virol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0110","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1073\/pnas.70.9.2487","article-title":"Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus","volume":"70","author":"Shope","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0115","first-page":"517","article-title":"Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficienct mice","volume":"137","author":"Okano","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.1.3.300","article-title":"Epstein-Barr virus and human diseases: recent advances in diagnosis","volume":"1","author":"Okano","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/160.4.589","article-title":"Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases","volume":"160","author":"Katz","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.1312750","article-title":"Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism","volume":"255","author":"Sixbey","year":"1992","journal-title":"Science"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0140","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","article-title":"Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells","volume":"72","author":"Imai","year":"1998","journal-title":"J Virol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/08880019709030897","article-title":"Therapeutic approaches for sever Epstein-Barr virus infection","volume":"14","author":"Okano","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0150","first-page":"92","article-title":"Epidemiology of Hodgkin\u2019s disease","volume":"7","author":"Gutensohn","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin\u2019s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0160","first-page":"86","article-title":"Epstein-Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ijc.2910460509","article-title":"Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin\u2019s diseases","volume":"46","author":"Wu","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin\u2019s diseases","volume":"16","author":"Kuppers","year":"1998","journal-title":"Ann Rev Immunol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0175","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1182\/blood.V77.4.799.799","article-title":"Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathological and molecular analysis","volume":"77","author":"Su","year":"1991","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI114168","article-title":"CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA","volume":"84","author":"Kawa-Ha","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1099-1069(199705)15:2<71::AID-HON601>3.0.CO;2-U","article-title":"Natural killer cell lymphoma\/ leukemia: pathology and treatment","volume":"15","author":"Kwong","year":"1997","journal-title":"Hematol Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0200","first-page":"769","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0205","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","article-title":"Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein","volume":"91","author":"Imai","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0210","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/1097-0142(19871015)60:8<1771::AID-CNCR2820600817>3.0.CO;2-2","article-title":"Non-Hodgkin\u2019s lymphoma of the pleural cavity developing from long-standing pyothorax","volume":"60","author":"Iuchi","year":"1987","journal-title":"Cancer"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0215","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swardlow","year":"2008"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3960\/jslrt.46.5","article-title":"Pyothorax-associated lymphoma","volume":"46","author":"Aozasa","year":"2006","journal-title":"J Clinic Exp Hematopathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0230","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classical Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0235","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(78)91744-0","article-title":"Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion","volume":"ii","author":"Virelizier","year":"1978","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0245","first-page":"280","article-title":"A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection","volume":"130","author":"Joncas","year":"1984","journal-title":"Can Med Assoc J"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0250","first-page":"932","article-title":"Study of six patients with atypical lymphoproliferation associated with active Epstein-Barr virus infection in Japanese]","volume":"91","author":"Okano","year":"1987","journal-title":"J Jpn Pediatr Soc"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/157.3.405","article-title":"The chronic mononucleosis syndrome","volume":"157","author":"Straus","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CMR.4.1.129","article-title":"Severe chronic active Epstein-Barr virus infection syndrome","volume":"4","author":"Okano","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/333455a0","article-title":"Epstein-Barr virus genomepositive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease","volume":"333","author":"Kikuta","year":"1988","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0270","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.V91.6.2085","article-title":"A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma","volume":"91","author":"Kanegane","year":"1998","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0275","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446","article-title":"Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection","volume":"87","author":"Imai","year":"1996","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0280","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0290","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28 year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV+ T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0300","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000203693","article-title":"Full presence of Epstein-Barr virus (EBV)-encoded latent proteins in tissues from a patient with severe chronic active EBV infection syndrome","volume":"97","author":"Okano","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0310","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"\u00d7-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease)","volume":"i","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0315","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoprolifera-tive-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0320","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffee","year":"1998","journal-title":"Nature Genet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0325","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12026-008-8048-7","article-title":"X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses","volume":"42","author":"Bassiri","year":"2008","journal-title":"Immunol Res"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2010.01.002","article-title":"Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development","volume":"130","author":"Nagy","year":"2010","journal-title":"Immunol Let"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0340","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0345","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0355","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0360","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","article-title":"Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)","volume":"8","author":"Brandau","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0365","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0370","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-inducible T cell kinase deficiency: clinical presentation and therapeutic approach","volume":"96","author":"Stepensky","year":"2011","journal-title":"Haematologica"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0375","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9629(15)40780-3","article-title":"A review of Epstein-Barr virus infection in patients with immunodeficiency","volume":"319","author":"Okano","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0380","first-page":"200","article-title":"Immunodeficiency-associated lymphoproliferative disorders","volume":"12","author":"Knowles","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0385","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1086\/313704","article-title":"Detection of Epstein-Barr virus in posttransplantation T cell lymphoma in a kidney transplant recipient: case report and review","volume":"30","author":"Frias","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr virusnegative post-transplant lymphoproliferative disorders: a distinct entity?","volume":"24","author":"Nelson","year":"2000","journal-title":"Am J Surg Pathol."},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0395","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0400","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1097\/MAJ.0b013e318236e02d_bb0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1097\/MAJ.0b013e318236e02d_bb0410","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-065X.1997.tb00984.x","article-title":"Adoptive cellular immunotherapy for EBV lymphoproliferative disease","volume":"157","author":"Heslop","year":"1997","journal-title":"Immunol Rev"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915309435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915309435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T05:18:00Z","timestamp":1639718280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915309435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0002962915309435"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e318236e02d","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}